Altered Peptide Ligands of Islet Autoantigen Imogen 38 Inhibit Antigen Specific T Cell Reactivity in Human Type-1 Diabetes
- 31 August 1998
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 11 (4) , 353-361
- https://doi.org/10.1006/jaut.1998.0207
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A TCR Binds to Antagonist Ligands with Lower Affinities and Faster Dissociation Rates Than to AgonistsImmunity, 1996
- Altered Peptide Ligand–Induced Partial T Cell Activation: Molecular Mechanisms and Role in T Cell BiologyAnnual Review of Immunology, 1996
- Kinetic discrimination in T-cell activation.Proceedings of the National Academy of Sciences, 1996
- Identification of a motif for HLA-DR1 binding peptides using M13 display libraries.The Journal of Experimental Medicine, 1992
- Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptorCell, 1992
- T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetesThe Lancet, 1991
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteinsNature, 1990
- Human T cell clones with specificity for insulinoma cell antigensEuropean Journal of Immunology, 1989
- Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.The Journal of Experimental Medicine, 1987